Athira Pharma Inc ATHA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
3.75quote price arrow up+0.03 (+0.89%)
Volume
593
Close
3.71quote price arrow down-0.08 (-2.24%)
Volume
288,729
52 week range
2.53 - 14.22
Loading...
  • Open3.80
  • Day High3.87
  • Day Low3.68
  • Prev Close3.80
  • 52 Week High14.22
  • 52 Week High Date04/04/22
  • 52 Week Low2.53
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap140.536M
  • Shares Out37.83M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change17.19

KEY STATS

  • Open3.80
  • Day High3.87
  • Day Low3.68
  • Prev Close3.80
  • 52 Week High14.22
  • 52 Week High Date04/04/22
  • 52 Week Low2.53
  • 52 Week Low Date06/22/22
  • Market Cap140.536M
  • Shares Out37.83M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change17.19

RATIOS/PROFITABILITY

  • EPS (TTM)-2.10
  • P/E (TTM)-1.77
  • Fwd P/E (NTM)-1.26
  • EBITDA (TTM)-89.135M
  • ROE (TTM)-27.35%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/24/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Athira Pharma Inc

 

Profile

MORE
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company's lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, blood brain barrier (BBB)-penetrating, small molecule HGF/MET positive modulator. The primary target indication is Alzheimers disease. The ATH-1017, is a subcutaneous administered, BBB-penetrating, small molecule...
Kelly Romano
Independent Chairwoman of the Board
Mark Litton Ph.D.
President, Chief Executive Officer, Director
Rachel Lenington
Chief Operating Officer
Glenna Mileson
Chief Financial Officer
Mark Worthington
General Counsel, Corporate Secretary
Address
18706 North Creek Parkway
Suite 104, Box 352141
Bothell, WA
98011
United States

Top Peers

SYMBOLLASTCHG%CHG
BIVI
BioVie Inc
5.41-0.28-4.92%
CELC
Celcuity Inc
9.77+0.37+3.94%
INMB
INmune Bio Inc
8.60UNCHUNCH
GRCL
Gracell Biotechnologies Inc
2.11-0.02-0.94%
KRON
Kronos Bio Inc
2.27-0.16-6.58%